Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Abstract Background Dysregulated production of interleukin (IL)-6 is implicated in the pathology of inflammatory bowel disease (IBD). Neutralization of IL-6 in the gut by safe probiotic bacteria may help alleviate intestinal inflammation. Here, we developed Lactococcus lactis with potent and selecti...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2022-07-01
|
| Colección: | Microbial Cell Factories |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12934-022-01873-7 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|